Basics Alumis Inc. Common Stock IPO Date: June 28, 2024 Sector: Healthcare Industry: Biotech Market Cap: $1.16B Activated in VL: True Average Daily Range Avg Daily Range: $0.30 | 4.26% Avg Daily Range (30 D): $0.29 | 4.45% Avg Daily Range (90 D): $0.17 | 3.08% Institutional Daily Volume Avg Daily Volume: .46M Avg Daily Volume (30 D): 1.03M Avg Daily Volume (90 D): .71M Trade Size Avg Trade Size (Sh.): 89 Avg Trade Size (Sh.) (30 D): 98 Avg Trade Size (Sh.) (90 D): 94 Institutional Trades Total Inst.Trades: 61 Avg Inst. Trade: $1.42M Avg Inst. Trade (30 D): $.76M Avg Inst. Trade (90 D): $.93M Avg Inst. Trade Volume: .2M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.01M Avg Closing Trade (30 D): $.67M Avg Closing Trade (90 D): $.98M Avg Closing Volume: 271.85K     News Oct 16, 2025 @ 5:00 PM Thyroid Eye Disease Clinical Trial Pipeline Gains ... Source: Delveinsight Aug 13, 2025 @ 8:28 PM Alumis Misses Q2 Revenue as Costs Jump Source: Na May 21, 2025 @ 1:10 PM Alumis Completes Merger with ACELYRIN Source: Globe Newswire May 13, 2025 @ 5:00 PM Alumis Stockholders Approve Merger with ACELYRIN Source: N/A May 13, 2025 @ 5:00 PM ACELYRIN Stockholders Approve Merger with Alumis t... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $-2.15 $-1.06 Diluted EPS $-2.15 $-1.06 Revenue $ 22.12M $ 2.07M $ Gross Profit $ $ $ Net Income / Loss $ -245.15M $ -110.75M $ 59.32M Operating Income / Loss $ -455.98M $ -115.29M $ Cost of Revenue $ $ $ Net Cash Flow $ -147.81M $ $ PE Ratio